Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer
Condition: Triple Negative Breast Cancer Interventions: Drug: Gemcitabine and carboplatin plus antibiotic (moxifloxacin); Drug: Gemcitabine combined with carboplatin plus placebo Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2021 Category: Research Source Type: clinical trials
Effects of moxifloxacin and gemifloxacin on blood glucose level of euglycemics:a pre-clinical and clinical study
Conditions: Dysglycemia; Blood Glucose, Low Interventions: Drug: Moxifloxacin 400mg; Drug: Gemifloxacin 320 MG Sponsor: Shaheed Benazir Bhutto University Sheringal Dir Upper Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2021 Category: Research Source Type: clinical trials
Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
Conditions: Symptomatic Neurogenic Orthostatic Hypertension; nOH Interventions: Drug: Ampreloxetine ; Drug: Ampreloxetine ; Drug: Ampreloxetine Placebo; Drug: Moxifloxacin; Drug: Moxifloxacin Placebo Sponsor: Theravance Biopharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2020 Category: Research Source Type: clinical trials
A Study of the Cardiac Effects of ALXN2050 in Healthy Adults
Condition: Healthy Interventions: Drug: ALXN2050; Drug: ALXN2050-matching Placebo; Drug: Moxifloxacin; Drug: Moxifloxacin-matching Placebo Sponsors: Alexion Pharmaceuticals; Celerion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2020 Category: Research Source Type: clinical trials
Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin
Condition: HIV Infections Interventions: Drug: GSK3640254; Drug: Placebo; Drug: Moxifloxacin Sponsor: ViiV Healthcare Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2020 Category: Research Source Type: clinical trials
A Study of the Cardiac Effects of ALXN1840 in Healthy Adults
Condition: Healthy Interventions: Drug: ALXN1840; Drug: Placebo; Drug: Moxifloxacin Sponsors: Alexion Pharmaceuticals; PPD; ERT: Clinical Trial Technology Solutions Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 23, 2020 Category: Research Source Type: clinical trials
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)
Conditions: Infections and Infestations; Pulmonary Tuberculosis Interventions: Drug: Delpazolid; Drug: Bedaquiline, Delamanid, Moxifloxacin Sponsors: LegoChem Biosciences, Inc; Ludwig-Maximilians - University of Munich; Radboud University; University of California, San Francisco Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2020 Category: Research Source Type: clinical trials
